Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
517
datasets available to search
ShareScore release 0.9.0
Dataset results
517 results for “Checkpoint inhibitors”
Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial
ClinicalTrials.gov study NCT06470971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
ClinicalTrials.gov study NCT04260256. IPD Sharing: NO. Countries: 1. Publications: 0.
Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy
ClinicalTrials.gov study NCT06414304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Palliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
ClinicalTrials.gov study NCT05440916. IPD Sharing: NO. Countries: 1. Publications: 0.
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
ClinicalTrials.gov study NCT04691817. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitor Therapy- Induced Endocrinopathy
ClinicalTrials.gov study NCT04079647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients
ClinicalTrials.gov study NCT05641545. IPD Sharing: NO. Countries: 1. Publications: 0.
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
ClinicalTrials.gov study NCT05187338. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-
ClinicalTrials.gov study NCT06772623. IPD Sharing: YES. Countries: 9. Publications: 0.
A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer
ClinicalTrials.gov study NCT03762161. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
ClinicalTrials.gov study NCT07148245. IPD Sharing: YES. Countries: 1. Publications: 0.
The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy
ClinicalTrials.gov study NCT04670107. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）
ClinicalTrials.gov study NCT05781074. IPD Sharing: NO. Countries: 1. Publications: 0.
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
ClinicalTrials.gov study NCT04038619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC
ClinicalTrials.gov study NCT06132698. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
ClinicalTrials.gov study NCT06463665. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT05204862. IPD Sharing: NO. Countries: 2. Publications: 0.
Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT03945253. IPD Sharing: NO. Countries: 1. Publications: 0.
Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors
ClinicalTrials.gov study NCT05039073. IPD Sharing: NO. Countries: 1. Publications: 0.
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
ClinicalTrials.gov study NCT05927142. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.